Egerton Capital (UK) LLP: APPLIED MATLS INC (AMAT): Quarterly 13F Position History
As of Q2 2026, Egerton Capital (UK) LLP reported 521,065 shares of APPLIED MATLS INC (AMAT), worth $376.7M and representing 3.6% of its 13F equity book. Quarter-over-quarter share count change: + 521,065 (re-initiated) . The position first appeared in Q1 2017 and has been disclosed across 38 13F-HR filings in Pactolio's tracked window.
- 521,065Shares Held (Latest Filing)
- $376.7MReported Market Value (Latest Filing)
- 3.6%Portfolio Weight (% of 13F Equity Book)
- +521,065Quarter-over-Quarter Share Change
- +$376.7MQuarter-over-Quarter Value Change
- 16,919,928Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 38 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q2 2026 | 521,065 | +521,065 | — | $376.7M | 3.6% | $723.0 |
| Q1 2026 | 0 | 0 | — | $0 | 0.0% | — |
| Q4 2025 | 0 | 0 | — | $0 | 0.0% | — |
| Q3 2025 | 0 | 0 | — | $0 | 0.0% | — |
| Q2 2025 | 0 | 0 | — | $0 | 0.0% | — |
| Q1 2025 | 0 | 0 | — | $0 | 0.0% | — |
| Q4 2024 | 0 | 0 | — | $0 | 0.0% | — |
| Q3 2024 | 0 | 0 | — | $0 | 0.0% | — |
| Q2 2024 | 0 | 0 | — | $0 | 0.0% | — |
| Q1 2024 | 0 | 0 | — | $0 | 0.0% | — |
| Q4 2023 | 0 | 0 | — | $0 | 0.0% | — |
| Q3 2023 | 0 | 2,629,188 | -100.0% | $0 | 0.0% | — |
| Q2 2023 | 2,629,188 | 92,953 | -3.4% | $380.0M | 3.9% | $144.5 |
| Q1 2023 | 2,722,141 | +252,285 | +10.2% | $334.4M | 3.6% | $122.8 |
| Q4 2022 | 2,469,856 | 3,393,546 | -57.9% | $240.5M | 2.1% | $97.4 |
| Q3 2022 | 5,863,402 | +956,360 | +19.5% | $480.4M | 3.7% | $81.9 |
| Q2 2022 | 4,907,042 | +2,906,043 | +145.2% | $446.4M | 3.0% | $91.0 |
| Q1 2022 | 2,000,999 | +2,000,999 | — | $263.7M | 1.4% | $131.8 |
| Q4 2021 | 0 | 0 | — | $0 | 0.0% | — |
| Q3 2021 | 0 | 0 | — | $0 | 0.0% | — |
| Q2 2021 | 0 | 0 | — | $0 | 0.0% | — |
| Q1 2021 | 0 | 0 | — | $0 | 0.0% | — |
| Q4 2020 | 0 | 0 | — | $0 | 0.0% | — |
| Q3 2020 | 0 | 0 | — | $0 | 0.0% | — |
| Q2 2020 | 0 | 0 | — | $0 | 0.0% | — |
| Q1 2020 | 0 | 0 | — | $0 | 0.0% | — |
| Q4 2019 | 0 | 0 | — | $0 | 0.0% | — |
| Q3 2019 | 0 | 0 | — | $0 | 0.0% | — |
| Q2 2019 | 0 | 0 | — | $0 | 0.0% | — |
| Q1 2019 | 0 | 0 | — | $0 | 0.0% | — |
| Q4 2018 | 0 | 0 | — | $0 | 0.0% | — |
| Q3 2018 | 0 | 2,373,671 | -100.0% | $0 | 0.0% | — |
| Q2 2018 | 2,373,671 | 8,684,066 | -78.5% | $109.6M | 0.8% | $46.2 |
| Q1 2018 | 11,057,737 | 4,433,463 | -28.6% | $614.9M | 5.0% | $55.6 |
| Q4 2017 | 15,491,200 | 1,428,728 | -8.4% | $791.9M | 6.9% | $51.1 |
| Q3 2017 | 16,919,928 | +3,184,994 | +23.2% | $881.4M | 7.9% | $52.1 |
| Q2 2017 | 13,734,934 | +2,092,326 | +18.0% | $567.4M | 5.7% | $41.3 |
| Q1 2017 | 11,642,608 | — | — | $452.9M | 4.9% | $38.9 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.
When did Egerton Capital (UK) LLP first disclose a AMAT position in 13F-HR filings?
Egerton Capital (UK) LLP first reported APPLIED MATLS INC (AMAT) on its 13F-HR filing for the period ending 2017-03-31 (Q1 2017). The position has appeared on 38 reported quarters within Pactolio's tracked window.
What was Egerton Capital (UK) LLP's most recent quarter-over-quarter share-count change in AMAT?
Between Q1 2026 and Q2 2026, Egerton Capital (UK) LLP added 521,065 shares of AMAT (re-initiated), bringing the total reported position to 521,065 shares at a market value of $376.7M.
Does the implied price-per-share represent Egerton Capital (UK) LLP's cost basis in AMAT?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.